Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Winter;8(1):1-7.

Surveillance strategies for renal cell carcinoma patients following nephrectomy

Arnold I Chin, John S Lam, Robert A Figlin, Arie S Belldegrun

Surveillance strategies for renal cell carcinoma patients following nephrectomy

Arnold I Chin et al. Rev Urol. 2006 Winter.

Abstract

Renal cell carcinoma (RCC) is the most lethal of urologic malignancies, accounting for an estimated 36,000 new cases of carcinoma and 12,000 deaths in 2005. Nephrectomy is the usual treatment; however, after nephrectomy, RCC recurs in 20% to 40% of patients with clinically localized disease. A consensus surveillance protocol does not exist for follow-up of RCC after nephrectomy. In this article, available protocols are reviewed with a goal of developing an evidence-based system including the prognostic factors for recurrent disease, chronology and sites of recurrence, available treatment options if recurrent disease is found, and modalities of diagnostic testing available to urologists. New surveillance recommendations are presented based on prognostic factors as well as the University of California, Los Angeles Integrated Staging System for RCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier survival analysis of 661 patients based on prognostic indicators incorporated into University of California Los Angeles Integrated Staging System for renal cell carcinoma. (A) Survival curves based on 1997 tumor, nodes, metastasis (TNM) stages I–IV; (B) Survival curves based on Fuhrman grades 1–4. (C) Survival curves based on Eastern Cooperative Oncology Group performance status. Reproduced with permission from Zisman A et al.
Figure 2
Figure 2
University of California Los Angeles Integrated Staging for patients with localized renal cell carcinoma. Using the T stage, Fuhrman grade, and Eastern Cooperative Oncology Group performance status (ECOG PS), patients are stratified into low-, intermediate-, and high-risk groups. Adapted from Zisman A et al.
Figure 3
Figure 3
Kaplan-Meier survival analysis of 3119 patients based on University of California Los Angeles Integrated Staging with localized renal cell carcinoma. CT, computerized tomography; LR, low risk; IR, intermediate risk; HR, high risk. Reproduced with permission from Patard JJ et al.
Figure 4
Figure 4
Surveillance protocol following nephrectomy for localized renal cell carcinoma using the University of California Los Angeles Integrated Staging System.
See this image and copyright information in PMC

References

    1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. - PubMed
    1. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30:843–852. - PubMed
    1. Lam JS, Shvarts O, Leppert JT, et al. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol. 2005;173:1853–1862. - PubMed
    1. Tsui KH, Shvarts O, Smith RB, et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol. 2000;163:1090–1095. quiz 1295. - PubMed
    1. Vasselli JR, Yang JC, Linehan WM, et al. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol. 2001;166:68–72. - PubMed

LinkOut - more resources